Supplement to Canatu Plc’s company release on 10 February 2025: Canatu Plc’s new series A shares subscribed for with investors warrants have been registered with the Finnish Trade Register
Canatu Plc Company release 10 February 2025 at 21:30 pm EET
Supplement to Canatu Plc’s company release on 10 February 2025: Canatu Plc’s new series A shares subscribed for with investors warrants have been registered with the Finnish Trade Register
Canatu Plc (the “Company”) supplements the company release published on 10 February 2025 regarding the registration of the Company’s new series A shares. There has been a change in the date for the admission to public trading of the new series A shares disclosed in the previous company release, 11 February 2025, and the new series A shares subscribed for with investor warrants will be admitted to public trading on the Nasdaq First North Growth Market Finland marketplace together with the pre-existing series A shares on or about 12 February 2025.
Additional information
CEO Juha Kokkonen, tel. +358 405 430 367
Member of the Board of Directors Tuomo Vähäpassi, tuomo.vahapassi@lifeline-spac1.com
Certified adviser
Carnegie Investment Bank AB (publ), tel. +46 (0)73 856 42 65
About Canatu
Canatu (CANATU, Nasdaq First North, Finland) is a fast-growing deep technology company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.
Canatu’s versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling the manufacturing of the most advanced chips, as well as film heaters for advanced driver-assistance systems (ADAS) in the automotive industry. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Dry DepositionTM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.
Headquartered in Finland, Canatu also operates in the US, Japan, and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has around 130 employees representing over 30 nationalities, with 20 percent holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn.
